Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Buser

Showing results (41-50 of 104) with videos related to

Pageof 11
Sort By:
Oncotarget|June 28, 2014
Niraparib (MK-4827), a novel poly(ADP-Ribose) polymerase inhibitor, radiosensitizes human lung and breast cancer cellsKathleen A Bridges, Carlo Toniatti, Carolyn A Buser, et al.
Vox Sanguinis|November 25, 2010
A pilot iron substitution programme in female blood donors with iron deficiency without anaemiaC Pittori, A Buser, U E Gasser, et al.
Bone Marrow Transplantation|August 11, 2010
Cyclosporine levels and rate of graft rejection following non-myeloablative conditioning for allogeneic hematopoietic SCTS Gerull, C Arber, C Bucher, et al.
Vox Sanguinis|November 22, 2016
Iron deficiency and thrombocytosisA Holbro, T Volken, A Buser, et al.
Bioengineering & Translational Medicine|May 19, 2023
Genetically engineered pair of cells for serological testing and its application for SARS-CoV-2Marvin A Ssemadaali, Juan Arredondo, Elise A Buser, et al.
Bone Marrow Transplantation|August 13, 2008
Impaired B-cell reconstitution in lymphoma patients undergoing allogeneic HSCT: an effect of pretreatment with rituximab?A Buser, M Stern, C Arber, et al.
Bone Marrow Transplantation|June 27, 2017
Inability to work and need for disability pension among long-term survivors of hematopoietic stem cell transplantationA Tichelli, S Gerull, A Holbro, et al.
Bone Marrow Transplantation|September 27, 2005
Transplant-associated microangiopathy (TAM) in recipients of allogeneic hematopoietic stem cell transplantsM T Martinez, Ch Bucher, G Stussi, et al.
Bone Marrow Transplantation|June 16, 2010
Order of application and liver toxicity in patients given BU and CY containing conditioning regimens for allogeneic hematopoietic SCTN Cantoni, S Gerull, D Heim, et al.
British Journal of Pharmacology|August 18, 2012
Pharmacological characterization of designer cathinones in vitroL D Simmler, T A Buser, M Donzelli, et al.
Pageof 11

Showing results (41-50 of 104) with videos related to

Sort By:
Pageof 11
Oncotarget|June 28, 2014
Niraparib (MK-4827), a novel poly(ADP-Ribose) polymerase inhibitor, radiosensitizes human lung and breast cancer cellsKathleen A Bridges, Carlo Toniatti, Carolyn A Buser, et al.
Vox Sanguinis|November 25, 2010
A pilot iron substitution programme in female blood donors with iron deficiency without anaemiaC Pittori, A Buser, U E Gasser, et al.
Bone Marrow Transplantation|August 11, 2010
Cyclosporine levels and rate of graft rejection following non-myeloablative conditioning for allogeneic hematopoietic SCTS Gerull, C Arber, C Bucher, et al.
Vox Sanguinis|November 22, 2016
Iron deficiency and thrombocytosisA Holbro, T Volken, A Buser, et al.
Bioengineering & Translational Medicine|May 19, 2023
Genetically engineered pair of cells for serological testing and its application for SARS-CoV-2Marvin A Ssemadaali, Juan Arredondo, Elise A Buser, et al.
Bone Marrow Transplantation|August 13, 2008
Impaired B-cell reconstitution in lymphoma patients undergoing allogeneic HSCT: an effect of pretreatment with rituximab?A Buser, M Stern, C Arber, et al.
Bone Marrow Transplantation|June 27, 2017
Inability to work and need for disability pension among long-term survivors of hematopoietic stem cell transplantationA Tichelli, S Gerull, A Holbro, et al.
Bone Marrow Transplantation|September 27, 2005
Transplant-associated microangiopathy (TAM) in recipients of allogeneic hematopoietic stem cell transplantsM T Martinez, Ch Bucher, G Stussi, et al.
Bone Marrow Transplantation|June 16, 2010
Order of application and liver toxicity in patients given BU and CY containing conditioning regimens for allogeneic hematopoietic SCTN Cantoni, S Gerull, D Heim, et al.
British Journal of Pharmacology|August 18, 2012
Pharmacological characterization of designer cathinones in vitroL D Simmler, T A Buser, M Donzelli, et al.
Pageof 11